You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PRECOSE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Precose, and what generic alternatives are available?

Precose is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in PRECOSE is acarbose. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acarbose profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Precose

A generic version of PRECOSE was approved as acarbose by HIKMA on May 7th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PRECOSE?
  • What are the global sales for PRECOSE?
  • What is Average Wholesale Price for PRECOSE?
Summary for PRECOSE
Drug patent expirations by year for PRECOSE
Drug Prices for PRECOSE

See drug prices for PRECOSE

Recent Clinical Trials for PRECOSE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Montefiore Medical CenterPhase 2
Zhongda HospitalPhase 4
University of British ColumbiaPhase 2

See all PRECOSE clinical trials

Paragraph IV (Patent) Challenges for PRECOSE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PRECOSE Tablets acarbose 25 mg, 50 mg and 100 mg 020482 1 2005-03-22

US Patents and Regulatory Information for PRECOSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-004 May 29, 1997 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-001 Sep 6, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-002 Sep 6, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PRECOSE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-004 May 29, 1997 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-002 Sep 6, 1995 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-001 Sep 6, 1995 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PRECOSE

See the table below for patents covering PRECOSE around the world.

Country Patent Number Title Estimated Expiration
Hungary 196219 PROCESS FOR PREPARING ACARBOSE OF HIGH PURITY FURTHER PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUND AS ACTIVE INGREDIENT ⤷  Sign Up
Denmark 164870 ⤷  Sign Up
Bulgaria 49497 METHOD FOR PREPARING AKARBOZA ⤷  Sign Up
Germany 3543999 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.